Bicycle Share Price

Bicycle Share Price

NASDAQ: BCYC | Micro Cap | Healthcare
$2.90
-$0.15 (-4.76%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Bicycle Stock Performance

Open
$2.98
Prev. Close
$3.04
Circuit Range
N/A
Day Range
$2.87 - $2.98
Year Range
$2.87 - $7.76
Volume
83,578
Average Traded
$2.91

Bicycle Share Price Today

As of 22 November 2026, Bicycle Therapeutics plc's share price is $2.90. The stock opened at $2.98, compared to its previous close of $3.04. During today's trading session, Bicycle Therapeutics plc's share price traded between $2.87 and $2.98, with an average price of $2.92. Over the past 52 weeks, the stock has recorded a high of $7.76 and a low of $2.87. In terms of performance, Bicycle Therapeutics plc's share price has declined by 38.30% over the last six months and is down 61.31% on a year-on-year basis.

Bicycle Share Price Chart

Line chart of the Bicycle price trend over the selected period. The price fell overall, ranging from 2.85 to 2.98, ending at 2.90.
$2.87$2.98
L
Show Current Price
H

Bicycle Stock Fundamentals & Key Indicators

Market Cap
$200.91M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.02
Revenue (TTM)
$72.59B
Return On Equity (TTM)
-28.06%
Profit Margin
-301.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
47.99%

Bicycle Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$47.96$0.89$0.63$34.06
Net Profit-$20.15-$60.83-$50.33-$10.48
Net Profit Margin-42.01%-6834.83%-7988.89%-30.77%
Income ChangeN/A-201.89%17.26%79.18%

Bicycle Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$14.46$26.98$35.28$72.59
Net Profit-$112.72-$180.66-$169.03-$218.96
Net Profit Margin-779.53%-669.61%-479.11%-301.64%
Income ChangeN/A-60.27%6.44%-29.54%

Bicycle Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets34.7128.2633.4841.23
Current Assets682.89928.61561.87369.38
Total Assets717.6956.87595.34410.61
Non Current Liabilities50.6496.58154.8886.48
Current Liabilities56.9867.2369.5453.34
Total Liabilities107.62163.81224.41139.83
Shareholders' Equity609.98793.06370.93270.78

Bicycle Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-249.68-164.72-60.63-86.11
Investing-2.35-1.24-2.93-18.99
Financing-0.13519.75250.036.69

About Bicycle

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Bicycle Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.75
$2.89
-21.57%
Oct 2026
$3.67
$3.69
-0.27%
Sep 2026
$4.11
$3.69
-14.67%
Aug 2026
$3.83
$4.33
+12.03%
Jul 2026
$4.29
$3.87
-9.06%
Jun 2026
$4.58
$4.25
-9.57%
May 2026
$4.71
$4.70
-0.42%
Apr 2026
$4.72
$4.72
+2.05%
Mar 2026
$5.68
$4.63
-19.43%
Feb 2026
$6.38
$5.74
-10.52%
Jan 2026
$7.09
$6.42
-9.01%
Dec 2025
$7.25
$7.05
-5.94%

Bicycle Share Price FAQs